Sapheon has announced the Health Canada approval for its VenaSeal sapheon closure system, designed to treat venous reflux disease (varicose veins). VenaSeal features a specially formulated medical adhesive that closes the saphenous vein. ...
US-based Sapheon has submitted the first module of pre-market approval (PMA) application to the US Food and Drug Administration (FDA) for its VenaSeal sapheon closure system, designed to treat venous reflux (varicose veins) disease. This ...
Tags: PMA Application, Medicine
Sapheon has reported one year follow-up results from a 38-patient clinical study of its VenaSeal Sapheon closure system, designed to treat saphenous vein disease. VenaSeal system, which comprises a proprietary vein sealant and custom ...
Sapheon, a developer of technologies for the treatment of vascular diseases, has completed the first closing in its $18.5m Series B Preferred equity offering. The company said the proceeds from the Series B offering will be used to ...